Ledger.Open graph →
SEC Form D · filed November 30, 2012

Pathway Therapeutics, Inc

Offering
$400K
Sold
$200K
Exemption
—
Industry
Biotechnology
Location
SAN FRANCISCO, CA
Type
—

People & firms on this filing (9)

Julie Cherrington · San Francisco, CAExec · DirectorPaul Goddard · San Francisco, CADirectorMark Perry · San Francisco, CADirectorJoshua Funder · Melbourne, Channel IslandsDirectorDarcy Garner Bhatia · New York, NYDirectorRyan D. Cahill · Evanston, ILExec · DirectorWill Morgan · San Francisco, CADirectorRichard G. Vincent · San Diego, CADirectorHillary Lewis · Mt. Eden, Auckland, Q2Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗